Company profile
Gentronix Limited
Gentronix - Experts in Predictive Toxicology
Gentronix provides services to help expedite the discovery, early-stage development and safe manufacture of novel drugs.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Sep 2023 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Mortgage Create With Deed With Charge Number Charge Creation Date
MortgageMR01 | Transaction MzQzNzAzMTA1OWFkaXF6a2N4
Published 28 Sep 2024 10:25
Resolution
ResolutionRESOLUTIONS | Transaction WURCS0JTNE9hZGlxemtjeA | Paper/PDF filed
Published 24 Sep 2024 07:05
Cessation Of A Person With Significant Control
Persons-with-significant-controlPSC07 | Transaction MzQzNTk4MTA0NGFkaXF6a2N4
Published 16 Sep 2024 09:37
Cessation Of A Person With Significant Control
Persons-with-significant-controlPSC07 | Transaction MzQzNTk4MDkyOWFkaXF6a2N4
Published 16 Sep 2024 09:36
Notification Of A Person With Significant Control
Persons-with-significant-controlPSC02 | Transaction MzQzNTk3NTA1NmFkaXF6a2N4
Published 16 Sep 2024 08:58
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTk3MzY3NWFkaXF6a2N4
Published 16 Sep 2024 08:50
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTk3MzcwM2FkaXF6a2N4
Published 16 Sep 2024 08:50
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTk3MzY5NGFkaXF6a2N4
Published 16 Sep 2024 08:50
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTk3MzY2MGFkaXF6a2N4
Published 16 Sep 2024 08:49
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzNTk3MzUyMGFkaXF6a2N4
Published 16 Sep 2024 08:48
Termination Secretary Company With Name Termination Date
OfficersTM02 | Transaction MzQzNTk3MzMxN2FkaXF6a2N4
Published 16 Sep 2024 08:48
Capital Allotment Shares
CapitalSH01 | Transaction MzQzNTkzNzk2NGFkaXF6a2N4
Published 16 Sep 2024 08:09
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQzNDQ5NTAxNGFkaXF6a2N4
Published 04 Sep 2024 13:23
Resolution
ResolutionRESOLUTIONS | Transaction WURBNTBaM0NhZGlxemtjeA | Paper/PDF filed
Published 28 Aug 2024 07:14
Memorandum Articles
IncorporationMA | Transaction MzQzMjYxMzA3NmFkaXF6a2N4 | Paper/PDF filed
Published 24 Aug 2024 07:02
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Reducing animal use through more accurate in vitro mutagenicity testing
1 Jul 2014 to 31 Jul 2014
Continued innovation by the diverse chemical sectors is expected to provide new, better, and more effective medicines, herbicides, pesticides and consumer products. The public expects these to be safe as well as effective. Cancer risk is perhaps the most concerning. The most potent carcinogens are mutagens: compounds that alter the DNA sequences in our ce...
Assessment of the feasibility of developing an in vitro screen for epigenetic mutagens
1 Feb 2013 to 30 Apr 2014
The human genome is complex and well protected by an array of systems that sense damage, and initiate repair. When damage is overwhelming, cells are usually forced into suicide to minimise the generation of viable mutant cells that might develop into tumours. Direct DNA damage is not the only threat to the genome. Tissues such as liver, kidney, muscle etc...